Research Article
No access
Published Online: 10 January 2019

Detection of West Nile Virus Infection in Viral Encephalitis Cases, China

Publication: Vector-Borne and Zoonotic Diseases
Volume 19, Issue Number 1

Abstract

This study detected West Nile virus (WNV) infection in serum samples of patients clinically diagnosed with viral encephalitis in the Japanese encephalitis virus (JEV) endemic area (seven provinces) and JEV nonendemic area (Xinjiang province) in China from 2011 to 2012. In JEV endemic areas, there were 22 positive cases of WNV immunoglobulin M (IgM) antibody in serum specimens of 65 JEV patients (JEV IgM antibody positive) in the acute phase, whereas WNV IgM antibodies were not detected in serum specimens of 63 non-JEV patients (JEV IgM antibody negative). However, the titer of JEV-neutralizing antibody was four times higher than that of WNV-neutralizing antibody in WNV-IgM-positive serum specimens. Detection was also conducted in serum specimens collected from 12 patients clinically diagnosed as viral encephalitis in Xinjiang; five serum specimens were WNV IgM antibody positive, and there were fourfold differences in WNV-neutralizing antibody titers between convalescent and acute serum. Meanwhile JEV-neutralizing antibody titer was negative or significantly lower than that of WNV-neutralizing antibody in the same specimens. WNV IgM antibodies positive were detected in acute serum specimens of patients clinically diagnosed with JEV infection in JEV-endemic areas, but no WNV neutralization antibodies were detected fourfold greater than that of the corresponding JEV antibodies. Clinical cases of WNV infection were detected in patients clinically diagnosed with viral encephalitis in Xinjiang.

Get full access to this article

View all available purchase options and get full access to this article.

References

Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989; 70:37–43.
Cao L, Fu S, Lv Z, Tang C, et al. West Nile virus infection in suspected febrile typhoid cases in Xinjiang, China. Emerg Microbes Infect 2017; 6:e41.
Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West Nile Virus: Biology, transmission, and human infection. Clin Microbiol Rev 2012; 25:635–648.
Gao X, Li X, Li M, Fu S, et al. Vaccine strategies for the control and prevention of Japanese encephalitis in mainland China, 1951–2011. PLoS Negl Trop Dis 2014; 8:e3015.
Gao X, Nasci R, Liang G. The neglected arboviral infections in mainland China. PLoS Negl Trop Dis 2010; 4:e624.
Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000; 38:4066–4071.
Li X, Cui S, Gao X, Wang H, et al. The spatio-temporal distribution of Japanese encephalitis cases in different age groups in mainland China, 2004–2014. PLoS Negl Trop Dis 2016; 10:e0004611.
Li X, Gao X, Ren Z, Cao Y, et al. A spatial and temporal analysis of Japanese encephalitis in mainland China, 1963–1975: A period without Japanese encephalitis vaccination. PLoS One 2014; 9:e99183.
Li XL, Fu SH, Liu WB, Wang HY, et al. West nile virus infection in Xinjiang, China. Vector Borne Zoonotic Dis 2013; 13:131–133.
Lindenbach BD, Thiel H-J, Rice CM. Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. Fifth ed. Philadelphia: Lippincott Williams and Wilkins, 2007:1101–1152.
Liu H, Gao X, Liang G. Newly recognized mosquito-associated viruses in mainland China, in the last two decades. Virol J 2011; 8:68.
Lu Z, Fu SH, Cao L, Tang CJ, et al. Human infection with West Nile Virus, Xinjiang, China, 2011. Emerg Infect Dis 2014; 20:1421–1423.
Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004; 10:S98–S109.
Mansfield KL, Horton DL, Johnson N, Li L, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol 2011; 92:2821–2829.
Martin DA, Muth DA, Brown T, Johnson AJ, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 2000; 38:1823–1826.
Miller RH, Masuoka P, Klein TA, Kim HC, et al. Ecological niche modeling to estimate the distribution of Japanese encephalitis virus in Asia. PLoS Negl Trop Dis 2012; 6:e1678.
Morales MA, Fabbri CM, Zunino GE, Kowalewski MM, et al. Detection of the mosquito-borne flaviviruses, West Nile, Dengue, Saint Louis Encephalitis, Ilheus, Bussuquara, and Yellow Fever in free-ranging black howlers (Alouatta caraya) of Northeastern Argentina. PLoS Negl Trop Dis 2017; 11:e0005351.
Pan XL, Liu H, Wang HY, Fu SH, et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol 2011; 85:9847–9853.
Pauvolid-Corrêa A, Campos Z, Juliano R, Velez J, et al. Serological evidence of widespread circulation of West Nile virus and other flaviviruses in equines of the Pantanal, Brazil. PLoS Negl Trop Dis 2014; 8:e2706.
Stiasny KO, Aberle SW, Heinz FX. Retrospective identification of human cases of West Nile virus infection in Austria (2009 to 2010) by serological differentiation from Usutu and other flavivirus infections. Euro Surveill 2013; 18:20614.
Wang H, Li Y, Liang X, Liang G. Japanese encephalitis in mainland China. Jpn J Infect Dis 2009; 62:331–336.
Wang HY, Takasaki T, Fu SH, Sun XH, et al. Molecular epidemiological analysis of Japanese encephalitis virus in China. J Gen Virol 2007; 88:885–894.
Wang L, Fu S, Zhang H, Ye X, et al. Identification and isolation of Genotype-I Japanese encephalitis virus from encephalitis patients. Virol J 2010; 7:345.
Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010; 85:328–345.
Zheng Y, Li M, Wang H, Liang G. Japanese encephalitis and Japanese encephalitis virus in mainland China. Rev Med Virol 2012; 22:301–322.

Information & Authors

Information

Published In

cover image Vector-Borne and Zoonotic Diseases
Vector-Borne and Zoonotic Diseases
Volume 19Issue Number 1January 2019
Pages: 45 - 50
PubMed: 29985780

History

Published online: 10 January 2019
Published in print: January 2019
Published ahead of print: 9 July 2018

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Lei Cao*
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Shihong Fu*
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Zhi Lu
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Chengjun Tang
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Xiaoyan Gao
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Xiaolong Li
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Wenwen Lei
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Ying He
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Minghua Li
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Yuxi Cao
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Huanyu Wang
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
Guodong Liang [email protected]
State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.

Notes

*
These authors contributed equally to this work.
Address correspondence to: Guodong Liang, State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Street, Xicheng District, Beijing 100052, China [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top